Is this you? Create Your Porfile
Avatar

Peter Hösel

Bayer HealthCare Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Peter Hösel is active.

Explore More

Publication

Featured researches published by Peter Hösel.

Archive | 2001

Novel solid body forms of mesoprogestin 11beta-{4e-(hydroxyiminomethyl)-phenyl}-17alpha methoxymethyl-17 beta-methoxy-estra-4,9-dien-3-one

Detlef Grawe; Peter Hösel; Uwe Müller; Gabriele Winter

Archive | 2000

Wirkstoffhaltige Laminate für Transdermalsysteme

Wilfried Fischer; Detlef Grawe; Peter Hösel

Archive | 2001

New solid forms of mesoprogestin 11Beta-[4E-(hydroxyimino methyl)-phenyl]-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on

Detlef Grawe; Peter Hösel; Uwe Müller; Gabriele Winter

Archive | 2003

Method for producing crystals from pharmaceutical adjuvants, crystals obtained therefrom and the pharmaceutical use thereof

Detlef Grawe; Hagen Gerecke; Peter Hösel; Annette Eichardt; Sabine Gliesing; Uwe Müller

Archive | 2003

Process for production of steroid crystals, crystals obtained thereby and their use in pharmaceutical preparations

Detlef Grawe; Hagen Gerecke; Peter Hösel; Annette Eichardt; Sabine Gliesing; Uwe Müller

Archive | 2003

Process for the production of crystals, crystals obtainable s egun this, and their use in pharmaceutical formulations.

Annette Eichardt; Hagen Gerecke; Sabine Gliesing; Detlef Grawe; Peter Hösel; Uwe Müller

Archive | 2003

Procede pour produire des cristaux, cristaux ainsi obtenus et leur utilisation dans des formulations pharmaceutiques

Detlef Grawe; Hagen Gerecke; Peter Hösel; Annette Eichardt; Sabine Gliesing; Uwe Müller

Archive | 2003

Verfahren zum herstellen von kristallen, danach erhältliche kristalle und deren verwendung in pharmazeutischen formulierungen

Detlef Grawe; Hagen Gerecke; Peter Hösel; Annette Eichardt; Sabine Gliesing; Uwe Müller

Archive | 2001

Nouvelles formes solides de mesoprogestine 11beta- 4e-(hydroxyiminomethyl)-phenyle]-17alpha-methoxymethyle-17beta-methoxy-estra-4,9-diene-3-one

Detlef Grawe; Peter Hösel; Uwe Müller; Gabriele Winter

Archive | 2000

Laminated with a content of an active substance for transdermal systems.

Wilfried Fischer; Detlef Grawe; Peter Hösel

Explore More

Collaboration

Dive into the Peter Hösel's collaboration.

Top Co-Authors
Avatar

Detlef Grawe

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Uwe Müller

Henkel

View shared research outputs
Top Co-Authors
Avatar

Annette Eichardt

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Hagen Gerecke

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Sabine Gliesing

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Gabriele Winter

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Carsten Timpe

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Michael Dittgen

Schering AG

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge